The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo

Cancer Cell

Volumn 2, Issue 3, 2002, Pages 229-241

  Verschuren, Emmy W ^a   Klefstrom, Juha ^a   Evan, Gerard I ^a   Jones, Nic ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CYCLIN D; CYCLIN K; PROTEIN P19; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; CCNK PROTEIN, HUMAN; CYCLINE;

ANEUPLOIDY; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL POPULATION; CELL SURVIVAL; CENTROSOME; CONTROLLED STUDY; CYTOKINESIS; DNA SYNTHESIS; KAPOSI SARCOMA; LYMPHOMA; MITOSIS INHIBITION; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; VIRUS CARCINOGENESIS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CYTOLOGY; EMBRYO; FIBROBLAST; GENETIC TRANSDUCTION; GENETICS; HUMAN; HUMAN HERPESVIRUS 8; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; VIROLOGY;

KAPOSI SARCOMA ASSOCIATED HERPESVIRUS;

ANIMALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CENTROSOME; CYCLINS; EMBRYO; FIBROBLASTS; GENES, P53; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA; MICE; MICE, TRANSGENIC; POLYPLOIDY; SARCOMA, KAPOSI; TRANSDUCTION, GENETIC;

EID: 0036730664     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00123-X     Document Type: Article

References (55)

1. Andreassen, P.R., Lohez, O.D., Lacroix, F.B., and Margolis, R.L. (2001). Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 12, 1315-1328.
2. Bates, S., Phillips, A.C., Clark, P.A., Stott, F., Peters, G., Ludwig, R.L., and Vousden, K.H. (1998). p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125.
3. Boshoff, C., Schulz, T.F., Kennedy, M.M., Graham, A.K., Fisher, C., Thomas, A., McGee, J.O., Weiss, R.A., and O'Leary, J.J. (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1, 1274-1278.
4. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T., and Hannon, G.J. (1995). Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-557.
5. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., and Moore, P.S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
6. Child, E.S., and Mann, D.J. (2001). Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence. Oncogene 20, 3311-3322.
7. de Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.Y., Ferbeyre, G., Samuelson, A.V., Prives, C., Roussel, M.F., Sherr, C.J., and Lowe, S.W. (1998). E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12, 2434-2442.
8. Di Leonardo, A., Khan, S.H., Linke, S.P., Greco, V., Seidita, G., and Wahl, G.M. (1997). DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57, 1013-1019.
9. Ellis, M., Chew, Y.P., Fallis, L., Freddersdorf, S., Boshoff, C., Weiss, R.A., Lu, X., and Mittnacht, S. (1999). Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J. 18, 644-653.
10. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
11. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561.
12. Friborg, J., Jr., Kong, W., Hottiger, M.O., and Nabel, G.J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894.
13. Godden-Kent, D., Talbot, S.J., Boshoff, C., Chang, Y., Moore, P., Weiss, R.A., and Mittnacht, S. (1997). The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol. 71, 4193-4198.
14. Groth, A., Weber, J.D., Willumsen, B.M., Sherr, C.J., and Roussel, M.F. (2000). Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem. 275, 27473-27480.
15. Gurova, K.V., Kwek, S.S., Koman, I.E., Komarov, A.P., Kandel, E., Nikiforov, M.A., and Gudkov, A.V. (2002). Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor. Cancer Biol. Therapy 1, 39-44.
16. Hinchcliffe, E.H., and Sluder, G. (2001). "It takes two to tango": understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev. 15, 1167-1181.
17. Hueber, A.O., Zornig, M., Lyon, D., Suda, T., Nagata, S., and Evan, G.I. (1997). Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278, 1305-1309.
18. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T., and Weinberg, R.A. (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
19. Jeffrey, P.D., Tong, L., and Pavletich, N.P. (2000). Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev. 14, 3115-3125.
20. Jiang, W., Wells, N.J., and Hunter, T. (1999). Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6. Proc. Natl. Acad. Sci. USA 96, 6193-6198.
21. Juin, P., Hueber, A.O., Littlewood, T., and Evan, G. (1999). c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13, 1367-1381.
22. Jung, J.U., Stager, M., and Desrosiers, R.C. (1994). Virus-encoded cyclin. Mol. Cell. Biol. 14, 7235-7244.
23. Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F., and Sherr, C.J. (1998). Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95, 8292-8297.
24. Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G., and Sherr, C.J. (1997). Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659.
25. Katano, H., Sato, Y., and Sata, T. (2001). Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies. Cancer 92, 3076-3084.
26. Khan, S.H., and Wahl, G.M. (1998). p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res. 58, 396-401.
27. Klefstrom, J., Arighi, E., Littlewood, T., Jaattela, M., Saksela, E., Evan, G.I., and Alitalo, K. (1997). Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO J. 16, 7382-7392.
28. Lacey, K.R., Jackson, P.K., and Stearns, T. (1999). Cyclin-dependent kinase control of centrosome duplication. Proc. Natl. Acad. Sci. USA 96, 2817-2822.
29. Laman, H., Coverley, D., Krude, T., Laskey, R., and Jones, N. (2001). Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol. Cell. Biol. 21, 624-635.
30. Lanni, J.S., and Jacks, T. (1998). Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18, 1055-1064.
31. Li, M., Lee, H., Yoon, D.W., Albrecht, J.C., Fleckenstein, B., Neipel, F., and Jung, J.U. (1997). Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71, 1984-1991.
32. Lundberg, A.S., and Weinberg, R.A. (1998). Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753-761.
33. Mann, D.J., Child, E.S., Swanton, C., Laman, H., and Jones, N. (1999). Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J. 18, 654-663.
34. Matsumoto, Y., Hayashi, K., and Nishida, E. (1999). Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr. Biol. 9, 429-432.
35. Meraldi, P., Honda, R., and Nigg, E.A. (2002). Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53(-/-) cells. EMBO J. 21, 483-492.
36. Meraldi, P., Lukas, J., Fry, A.M., Bartek, J., and Nigg, E.A. (1999). Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat. Cell Biol. 1, 88-93.
37. Morgan, D.O. (1999). Regulation of the APC and the exit from mitosis. Nat. Cell Biol. 1, E47-E53.
38. Ohtsubo, M., Theodoras, A.M., Schumacher, J., Roberts, J.M., and Pagano, M. (1995). Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15, 2612-2624.
39. Ojala, P.M., Tiainen, M., Salven, P., Veikkola, T., Castanos-Velez, E., Sarid, R., Biberfeld, P., and Makela, T.P. (1999). Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res. 59, 4984-4989.
40. Ojala, P.M., Yamamoto, K., Castanos-Velez, E., Biberfeld, P., Korsmeyer, S.J., and Makela, T.P. (2000). The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell Biol. 2, 819-825.
41. Palmero, I., Pantoja, C., and Serrano, M. (1998). p19ARF links the tumour suppressor p53 to Ras. Nature 395, 125-126.
42. Phillips, A.C., Ernst, M.K., Bates, S., Rice, N.R., and Vousden, K.H. (1999). E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 4, 771-781.
43. Pomerantz, J., Schreiber-Agus, N., Liegeois, N.J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.W., et al. (1998). The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
44. Rivas, C., Thlick, A.E., Parravicini, C., Moore, P.S., and Chang, Y. (2001). Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75, 429-438.
45. Schmitt, C.A., Fridman, J.S., Yang, M., Baranov, E., Hoffman, R.M., and Lowe, S.W. (2002). Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1, 289-298.
46. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., and Lowe, S.W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
47. Stewart, Z.A., Leach, S.D., and Pietenpol, J.A. (1999). p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol. Cell. Biol. 19, 205-215.
48. Stewart, Z.A., and Pietenpol, J.A. (2001). p53 signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14, 243-263.
49. Stott, F.J., Bates, S., James, M.C., McConnell, B.B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K.H., and Peters, G. (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001-5014.
50. Swanton, C., Mann, D.J., Fleckenstein, B., Neipel, F., Peters, G., and Jones, N. (1997). Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390, 184-187.
51. Todaro, G.J., and Green, H. (1963). Quantitative studies of growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299-313.
52. Zhang, Y., and Lees, E. (2001). Identification of an overlapping binding domain on Cdc20 for Mad2 and anaphase-promoting complex: model for spindle checkpoint regulation. Mol. Cell. Biol. 21, 5190-5199.
53. Zhang, Y., Xiong, Y., and Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
54. Zhong, W., Wang, H., Herndier, B., and Ganem, D. (1996). Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. USA 93, 6641-6646.
55. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., and Roussel, M.F. (1998). Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433.